Ethical Standards for Clinical Trials Conducted in Third Countries: The New Strategy of the European Medicines Agency
Creator
Altavilla, Annagrazia
Bibliographic Citation
European journal of health law 2011 Jan; 18(1): 65-75
Abstract
Clinical trials increasingly occur on a global scale as industry and government sponsors in wealthy countries move trials to low- and middle-income countries. The globalization of clinical research raises important questions about the economical and ethical aspects of clinical research and the translation of trial results to clinical practice: which ethical standards are applied? Are trials results accurate and valid, and can they be extrapolated to other settings? This article provides an overview of the strategy approved by the European Medicines Agency (EMA) to clarify ethical standards for clinical research conducted outside the European Economic Area (EEA) and included in Marketing Authorization Applications. Reference to the EMA Reflection paper is made.
Date
2011-01Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
-
Effect of European Clinical Trials Directive on Academic Drug Trials in Denmark: Retrospective Study of Applications to the Danish Medicines Agency, 1993-2006
Berendt, Louise; Håkansson, Cecilia; Bach, Karin Friis; Dalhoff, Kim; Andreasen, Per Buch; Peterson, Lene Grejs; Anderson, Elin; Poulson, Henrik Enghusen (2008-01-05) -
European Drug Agency Calls for More Ethical Trials in Developing Countries
Day, Michael (2010-09-10)